NT4 containing tetra-branched neurotensin peptide theranostics (SetLance)

N/A

Report date: 2025/03/20 10:06:08

Base Information

Drug NameNT4 containing tetra-branched neurotensin peptide theranostics (SetLance)
Drug Alias Nametetra-branched neurotensin peptides (SetLance)
ClassificationBiologics > Protein drugs > Recombinant polypeptideDiagnostic agent (In vivo)
Mechanisms of ActionNeurotensin modulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSetLance Srl
China Registration ClassN/A

Develop Information

Active CompaniesSetLance Srl
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A